Posted by Michael Wonder on 29 Mar 2023
FDA grants breakthrough device designation to Aural Analytics for speech analytics software to be used in treatment of ALS
29 March 2023 - Aural Analytics today announced that its Speech Vitals - ALS technology has been granted designation as a breakthrough device by the US FDA.
Speech Vitals - ALS is a software application used in the collection and analysis of speech recordings to assist neurologists in the monitoring of amyotrophic lateral sclerosis in adults in both clinic and home environments.
